Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy

Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program

(2009) Torgrim Tandstad et al.   JOURNAL OF CLINICAL ONCOLOGY

European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II

(2008) Susanne Krege et al.   EUROPEAN UROLOGY

Randomized Phase III Trial Comparing Retroperitoneal Lymph Node Dissection With One Course of Bleomycin and Etoposide Plus Cisplatin Chemotherapy in the Adjuvant Treatment of Clinical Stage I Nonseminomatous Testicular Germ Cell Tumors: AUO Trial AH 01/94 by the German Testicular Cancer Study Group

(2008) Peter Albers et al.   JOURNAL OF CLINICAL ONCOLOGY

Estimating the Risk of Cancer Associated With Imaging Related Radiation During Surveillance for Stage I Testicular Cancer Using Computerized Tomography

(2008) Tatum V. Tarin et al.   JOURNAL OF UROLOGY

Computed Tomography and Radiation Exposure

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Late results of surveillance of clinical stage I nonseminoma germ cell testicular tumours: 17 years’ experience in a national study in New Zealand

(2003) B.M. Colls et al.   BJU INTERNATIONAL